Stock KROS KEROS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Keros Therapeutics, Inc.

Equities

KROS

US4923271013

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
48.69 USD -1.54% Intraday chart for Keros Therapeutics, Inc. +5.14% +22.46%
May. 28 Keros Therapeutics, Inc. Appoints Jean-Jacques Bienaimé to Its Board of Directors and to Serve as A Member of the Nominating Committee, Effective June 1, 2024 CI
May. 08 Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 MT

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bullish

Bullish

Resistance 54.19 70.48 70.48
Spread/Res.-10.15%-30.92%-30.92%
Spread/Supp.+5.14%+11.96%+13.18%
Support 46.31 43.49 43.02

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. KROS Stock
  4. Charts Keros Therapeutics, Inc.